Nur77 decreases atherosclerosis progression in apoE-/- mice fed a high-fat/high-cholesterol diet

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Hu, Yan Wei ^a   Zhang, Peng ^a   Yang, Jun Yao ^a   Huang, Jin Lan ^a   Ma, Xin ^a   Li, Shu Fen ^a   Zhao, Jia Yi ^a   Hu, Ya Rong ^a   Wang, Yan Chao ^a   Gao, Ji Juan ^a   Sha, Yan Hua ^a   Zheng, Lei ^a   Wang, Qian ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; CYTOKINE; LIPID; NUCLEAR RECEPTOR NUR77; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROTIC PLAQUE; CELL LEVEL; CELL MIGRATION; CHOLESTEROL DIET; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DOWN REGULATION; GENE EXPRESSION; LIPID ABSORPTION; LIPID DIET; LIPID STORAGE; MALE; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BLOTTING, WESTERN; CACO-2 CELLS; CELL LINE, TUMOR; CHOLESTEROL, DIETARY; DIET, HIGH-FAT; DISEASE PROGRESSION; FOAM CELLS; GENE EXPRESSION; HEP G2 CELLS; HUMANS; INFLAMMATION; LIPID METABOLISM; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 1; PHENYLACETATES; PLAQUE, ATHEROSCLEROTIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE;

EID: 84900316034     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0087313     Document Type: Article

References (43)

1. Braunwald E (1997) Shattuck lecture-cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med 337: 1360-1369.
2. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, et al. (1995) Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med 333: 1301-1307.
3. Panel AP (2006) Reducing residual cardiovascular risk: the relevance of raising high-density lipoprotein cholesterol in patients on cholesterol-lowering treatment. Diab Vasc Dis Res 3: S1-S12.
4. Li AC, Glass CK (2004) PPAR- and LXR-dependent pathways controlling lipid metabolism and the development of atherosclerosis. J Lipid Res 45: 2161-2173. (Pubitemid 39602963)
5. Martinez-Gonzalez J, Badimon L (2005) The NR4A subfamily of nuclear receptors: new early genes regulated by growth factors in vascular cells. Cardiovasc Res 65: 609-618. (Pubitemid 40138981)
6. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, et al. (1995) The nuclear receptor superfamily: the second decade. Cell 83: 835-839.
7. Maxwell MA, Cleasby ME, Harding A, Stark A, Cooney GJ, et al. (2005) Nur77 regulates lipolysis in skeletal muscle cells. Evidence for cross-talk between the beta-adrenergic and an orphan nuclear hormone receptor pathway. J Biol Chem 280: 12573-12584.
8. Pols TW, Ottenhoff R, Vos M, Levels JH, Quax PH, et al. (2008) Nur77 modulates hepatic lipid metabolism through suppression of SREBP1c activity. Biochem Biophys Res Commun 366: 910-916.
9. Chao LC, Wroblewski K, Zhang Z, Pei L, Vergnes L, et al. (2009) Insulin resistance and altered systemic glucose metabolism in mice lacking Nur77. Diabetes 58: 2788-2796.
10. Bonta PI, van Tiel CM, Vos M, Pols TW, van Thienen JV, et al. (2006) Nuclear receptors Nur77, Nurr1, and NOR-1 expressed in atherosclerotic lesion macrophages reduce lipid loading and inflammatory responses. Arterioscler Thromb Vasc Biol 26: 2288-2294. (Pubitemid 44465724)
11. Saggini A, Anogeianaki A, Maccauro G, Tete S, Salini V, et al. (2011) Cholesterol, cytokines and diseases. Int J Immunopathol Pharmacol 24: 567-581.
12. Osterud B, Bjorklid E (2003) Role of monocytes in atherogenesis. Physiol Rev 83: 1069-1112. (Pubitemid 37222268)
13. Hui DY, Labonte ED, Howles PN (2008) Development and physiological regulation of intestinal lipid absorption. III. Intestinal transporters and cholesterol absorption. Am J Physiol Gastrointest Liver Physiol 294: G839-G843. (Pubitemid 351520052)
14. Zhao Y, Bruemmer D (2010) NR4A orphan nuclear receptors: transcriptional regulators of gene expression in metabolism and vascular biology. Arterioscler Thromb Vasc Biol 30: 1535-1541.
15. Pols TW, Bonta PI, de Vries CJ (2007) NR4A nuclear orphan receptors: protective in vascular disease? Curr Opin Lipidol 18: 515-520. (Pubitemid 47462203)
16. Ross R (1999) Atherosclerosis-an inflammatory disease. N Engl J Med 340: 115-126.
17. Rigamonti E, Chinetti-Gbaguidi G, Staels B (2008) Regulation of macrophage functions by PPAR-alpha, PPAR-gamma, and LXRs in mice and men. Arterioscler Thromb Vasc Biol 28: 1050-1059.
18. Ghosh S (2011) Macrophage cholesterol homeostasis and metabolic diseases: critical role of cholesteryl ester mobilization. Expert Rev Cardiovasc Ther 9: 329-340.
19. Babaev VR, Gleaves LA, Carter KJ, Suzuki H, Kodama T, et al. (2000) Reduced atherosclerotic lesions in mice deficient for total or macrophage-specific expression of scavenger receptor-A. Arterioscler Thromb Vasc Biol 20: 2593-2599.
20. Febbraio M, Guy E, Silverstein RL (2004) Stem cell transplantation reveals that absence of macrophage CD36 is protective against atherosclerosis. Arterioscler Thromb Vasc Biol 24: 2333-2338. (Pubitemid 39658038)
21. Hu YW, Zheng L, Wang Q (2010) Regulation of cholesterol homeostasis by liver X receptors. Clin Chim Acta 411: 617-625.
22. Gargalovic P, Dory L (2003) Caveolins and macrophage lipid metabolism. J Lipid Res 44: 11-21. (Pubitemid 36114765)
23. Oram JF, Heinecke JW (2005) ATP-binding cassette transporter A1: a cell cholesterol exporter that protects against cardiovascular disease. Physiol Rev 85: 1343-1372. (Pubitemid 41362273)
24. Moore KJ, Freeman MW (2006) Scavenger receptors in atherosclerosis: beyond lipid uptake. Arterioscler Thromb Vasc Biol 26: 1702-1711. (Pubitemid 44305322)
25. Hansson GK, Libby P (2006) The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 6: 508-519. (Pubitemid 43980523)
26. Packard RR, Libby P (2008) Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin Chem 54: 24-38. (Pubitemid 351182593)
27. Hamers AA, Vos M, Rassam F, Marinković G, Kurakula K, et al. (2012) Bone marrow-specific deficiency of nuclear receptor Nur77 enhances atherosclerosis. Circ Res 110: 428-38.
28. Kane JP (1983) Apolipoprotein B: structural and metabolic heterogeneity. Annu Rev Physiol 45: 637-650.
29. Pittman RC, Carew TE, Attie AD, Witztum JL, Watanabe Y, et al. (1982) Receptor-dependent and receptor-independent degradation of low density lipoprotein in normal rabbits and in receptor-deficient mutant rabbits. J Biol Chem 257: 7994-8000. (Pubitemid 13241222)
30. Davis RA, Hui TY (2001) 2000 George Lyman Duff Memorial Lecture: atherosclerosis is a liver disease of the heart. Arterioscler Thromb Vasc Biol 21: 887-898. (Pubitemid 34168642)
31. Pols TW, Ottenhoff R, Vos M, Levels JH, Quax PH, et al. (2008) Nur77 modulates hepatic lipid metabolism through suppression of SREBP1c activity. Biochem Biophys Res Commun 366: 910-916.
32. Chao LC, Wroblewski K, Zhang Z, Pei L, Vergnes L, et al. (2009) Insulin resistance and altered systemic glucose metabolism in mice lacking Nur77. Diabetes 58: 2788-2796.
33. Shi Y, Cheng D (2009) Beyond triglyceride synthesis: the dynamic functional roles of MGAT and DGAT enzymes in energy metabolism. Am J Physiol Endocrinol Metab 297: E10-8.
34. Yu L, Li-Hawkins J, Hammer RE, Berge KE, Horton JD, et al. (2002) Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol. J Clin Invest 110: 671-680. (Pubitemid 34988791)
35. Yu L, York J, von Bergmann K, Lutjohann D, Cohen JC, et al. (2003) Stimulation of cholesterol excretion by the liver X receptor agonist requires ATP-binding cassette transporters G5 and G8. J Biol Chem 278: 15565-15570. (Pubitemid 36799664)
36. Altmann SW, Davis HJ, Zhu LJ, Yao X, Hoos LM, et al. (2004) Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science 303: 1201-1204. (Pubitemid 38233587)
37. Davis HJ, Zhu LJ, Hoos LM, Tetzloff G, Maguire M, et al. (2004) Niemann-Pick C1 Like 1 (NPC1L1) is the intestinal phytosterol and cholesterol transporter and a key modulator of whole-body cholesterol homeostasis. J Biol Chem 279: 33586-33592. (Pubitemid 39063007)
38. Olofsson SO, Asp L, Boren J (1999) The assembly and secretion of apolipoprotein B-containing lipoproteins. Curr Opin Lipidol 10: 341-346. (Pubitemid 29419691)
39. Liu Y, Manchekar M, Sun Z, Richardson PE, Dashti N (2010) Apolipoprotein B-containing lipoprotein assembly in microsomal triglyceride transfer protein-deficient McA-RH7777 cells. J Lipid Res 51: 2253-2264.
40. Doran AC, Meller N, McNamara CA (2008) Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler Thromb Vasc Biol 28: 812-819. (Pubitemid 351544093)
41. Arkenbout EK, de Waard V, van Bragt M, van Achterberg TA, Grimbergen JM, et al. (2002) Protective function of transcription factor TR3 orphan receptor in atherogenesis: decreased lesion formation in carotid artery ligation model in TR3 transgenic mice. Circulation 106: 1530-1535.
42. de Waard V, Arkenbout EK, Vos M, Mocking AI, Niessen HW, et al. (2006) TR3 nuclear orphan receptor prevents cyclic stretch-induced proliferation of venous smooth muscle cells. Am J Pathol 168: 2027-2035. (Pubitemid 43825321)
43. Pires NM, Pols TW, de Vries MR, van Tiel CM, Bonta PI, et al. (2007) Activation of nuclear receptor Nur77 by 6-mercaptopurine protects against neointima formation. Circulation 115: 493-500. (Pubitemid 46184201)